VINBLASTINE for Malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where VINBLASTINE was used for Malignant melanoma.
Most Reported Side Effects for VINBLASTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 508 | 9.4% | 125 | 148 |
| Febrile neutropenia | 498 | 9.2% | 62 | 285 |
| Neutropenia | 416 | 7.7% | 74 | 175 |
| Drug ineffective | 302 | 5.6% | 68 | 62 |
| Product use in unapproved indication | 265 | 4.9% | 66 | 73 |
| Disease progression | 262 | 4.9% | 58 | 21 |
| Pyrexia | 259 | 4.8% | 26 | 166 |
| Neuropathy peripheral | 258 | 4.8% | 10 | 32 |
| Nausea | 215 | 4.0% | 25 | 127 |
| Vomiting | 172 | 3.2% | 24 | 105 |
| Malignant neoplasm progression | 170 | 3.2% | 45 | 35 |
| Second primary malignancy | 170 | 3.2% | 86 | 34 |
| Thrombocytopenia | 167 | 3.1% | 57 | 62 |
| Anaemia | 165 | 3.1% | 26 | 58 |
| Hodgkin's disease | 165 | 3.1% | 19 | 48 |
Other Indications for VINBLASTINE
Hodgkin's disease (2,866)
Product used for unknown indication (380)
Langerhans' cell histiocytosis (164)
Transitional cell carcinoma (116)
Bladder cancer (94)
Chemotherapy (86)
Non-hodgkin's lymphoma (59)
Hodgkin's disease nodular sclerosis (54)
Lymphoma (54)
Diffuse large b-cell lymphoma (52)
Other Drugs Used for Malignant melanoma
NIVOLUMAB (10,599)
IPILIMUMAB (8,903)
DABRAFENIB (5,277)
TRAMETINIB DIMETHYL SULFOXIDE (3,841)
PEMBROLIZUMAB (3,261)
BINIMETINIB (2,613)
ENCORAFENIB (2,591)
VEMURAFENIB (2,548)
TRAMETINIB (1,448)
COBIMETINIB (1,324)